Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
As CRISPR-Cas9 becomes the choicest genome editing contraption across the globe, winning its inventors the Kavli Prize for 2018, Indian scientists are using the nanotool to find fixes for diseases unique to the developing world.